UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC

The New England journal of medicine, 2023-07, Vol.389 (2), p.137-147

2023

Volltextzugriff (PDF)

AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer

The New England journal of medicine, 2015-04, Vol.372 (18), p.1689-1699

2015

Volltextzugriff (PDF)

Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study

The lancet oncology, 2020-03, Vol.21 (3), p.373-386

2020

Volltextzugriff (PDF)

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3327-3334

2013

Volltextzugriff (PDF)

Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component

Journal of clinical oncology, 2017-04, Vol.35 (12), p.1288-1296

2017

Volltextzugriff (PDF)

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

The lancet oncology, 2015-02, Vol.16 (2), p.141-151

2015

Volltextzugriff (PDF)

Phase 1 study of capmatinib in MET‐positive solid tumor patients: Dose escalation and expansion of selected cohorts

Cancer science, 2020-02, Vol.111 (2), p.536-547

2020

Volltextzugriff (PDF)

Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR -Mutated Non-Small Cell Lung Cancer

Cancer discovery, 2022-01, Vol.12 (1), p.74-89

2022

Volltextzugriff (PDF)

Rab37 in lung cancer mediates exocytosis of soluble ST2 and thus skews macrophages toward tumor‐suppressing phenotype

International journal of cancer, 2018-10, Vol.143 (7), p.1753-1763

2018

Volltextzugriff (PDF)

Iron oxide@chlorophyll clustered nanoparticles eliminate bladder cancer by photodynamic immunotherapy-initiated ferroptosis and immunostimulation

Journal of nanobiotechnology, 2022-08, Vol.20 (1), p.1-373, Article 373

2022

Volltextzugriff (PDF)

Elucidating Quantum Confinement in Graphene Oxide Dots Based On Excitation-Wavelength-Independent Photoluminescence

The journal of physical chemistry letters, 2016-06, Vol.7 (11), p.2087-2092

2016

Volltextzugriff (PDF)

The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis

PloS one, 2018-02, Vol.13 (2), p.e0192161-e0192161

2018

Volltextzugriff (PDF)

Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer

Radiology, 2012-08, Vol.264 (2), p.559-566

2012

Volltextzugriff (PDF)

Rab37 mediates trafficking and membrane presentation of PD-1 to sustain T cell exhaustion in lung cancer

Journal of biomedical science, 2024-02, Vol.31 (1), p.20-20, Article 20

2024

Volltextzugriff (PDF)

Dysregulation of Rab37-Mediated Cross-talk between Cancer Cells and Endothelial Cells via Thrombospondin-1 Promotes Tumor Neovasculature and Metastasis

Clinical cancer research, 2017-05, Vol.23 (9), p.2335-2345

2017

Volltextzugriff (PDF)

Biocompatible hole scavenger-assisted graphene oxide dots for photodynamic cancer therapy

Nanoscale, 2021-05, Vol.13 (18), p.8431-8441

2021

Volltextzugriff (PDF)

Psychometric evaluation of the WHOQOL-BREF, Taiwan version, across five kinds of Taiwanese cancer survivors: Rasch analysis and confirmatory factor analysis

Journal of the Formosan Medical Association, 2019-01, Vol.118 (1), p.215-222

2019

Volltextzugriff (PDF)

Impact of cooking oil fume exposure and fume extractor use on lung cancer risk in non-smoking Han Chinese women

Scientific reports, 2020-04, Vol.10 (1), p.6774, Article 6774

2020

Volltextzugriff (PDF)

Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial

The lancet oncology, 2012-05, Vol.13 (5), p.539-548

2012

Volltextzugriff (PDF)

The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapy

Scientific reports, 2022-02, Vol.12 (1), p.3319-3319, Article 3319

2022

Volltextzugriff (PDF)

FTY720 in resistant human epidermal growth factor receptor 2-positive breast cancer

Scientific reports, 2022-01, Vol.12 (1), p.241-241, Article 241

2022

Volltextzugriff (PDF)

Cost‐effectiveness of first‐line immunotherapies for advanced non‐small cell lung cancer

Cancer medicine (Malden, MA), 2023-04, Vol.12 (7), p.8838-8850

2023

Volltextzugriff (PDF)

Immune Checkpoint Inhibitor-Induced Myasthenia Gravis

Frontiers in neurology, 2020-07, Vol.11, p.634-634

2020

Volltextzugriff (PDF)

CD40 Pathway and IL-2 Expression Mediate the Differential Outcome of Colorectal Cancer Patients with Different CSF1R c.1085 Genotypes

International journal of molecular sciences, 2021-11, Vol.22 (22), p.12565

2021

Volltextzugriff (PDF)

1 – 25 von 1.288

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.106)
Mit Volltextzugriff
(1.178)

Publikationsform

Sprache

Englisch
(1.230)
Chinesisch
(49)
Japanisch
(13)
Koreanisch
(2)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(855)
Life Sciences & Biomedicine
(625)
Humans
(496)
Female
(322)
Male
(304)
Middle Aged
(247)
Aged
(215)
Adult
(203)
Oncology
(191)
Physical Sciences
(130)
Technology
(125)
Biological And Medical Sciences
(119)
Animals
(108)
Medical Sciences
(108)
Aged, 80 And Over
(104)
Patients
(97)
Lung Cancer
(94)
Risk Factors
(92)
Tumors
(87)
Science & Technology - Other Topics
(86)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(49)
中华血液学杂志
(38)
Cancer Research
(30)
Plos One
(28)
Journal Of Thoracic Oncology
(22)
Scientific Reports
(22)
Journal Of The Formosan Medical Association
(21)
Lung Cancer
(19)
Oncotarget
(18)
Japanese Journal Of Applied Physics
(17)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC

AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer

Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

Osimertinib in Pretreated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Phase II Extension Component

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials

Phase 1 study of capmatinib in MET‐positive solid tumor patients: Dose escalation and expansion of selected cohorts

Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR -Mutated Non-Small Cell Lung Cancer

Rab37 in lung cancer mediates exocytosis of soluble ST2 and thus skews macrophages toward tumor‐suppressing phenotype

Iron oxide@chlorophyll clustered nanoparticles eliminate bladder cancer by photodynamic immunotherapy-initiated ferroptosis and immunostimulation

Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial

Elucidating Quantum Confinement in Graphene Oxide Dots Based On Excitation-Wavelength-Independent Photoluminescence

The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis

Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer

Rab37 mediates trafficking and membrane presentation of PD-1 to sustain T cell exhaustion in lung cancer

Dysregulation of Rab37-Mediated Cross-talk between Cancer Cells and Endothelial Cells via Thrombospondin-1 Promotes Tumor Neovasculature and Metastasis

Biocompatible hole scavenger-assisted graphene oxide dots for photodynamic cancer therapy

Psychometric evaluation of the WHOQOL-BREF, Taiwan version, across five kinds of Taiwanese cancer survivors: Rasch analysis and confirmatory factor analysis

Impact of cooking oil fume exposure and fume extractor use on lung cancer risk in non-smoking Han Chinese women

Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial

The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapy

FTY720 in resistant human epidermal growth factor receptor 2-positive breast cancer

Cost‐effectiveness of first‐line immunotherapies for advanced non‐small cell lung cancer

Immune Checkpoint Inhibitor-Induced Myasthenia Gravis

CD40 Pathway and IL-2 Expression Mediate the Differential Outcome of Colorectal Cancer Patients with Different CSF1R c.1085 Genotypes

Suchergebnisse filtern